Semaglutide Improves Walking Capacity in Peripheral Artery Disease: STRIDE Trial
Researchers have found in the STRIDE trial that semaglutide significantly improved walking capacity in patients with peripheral artery disease (PAD). The benefit was consistent across different age groups and levels…